Inquiry Basket
Loading ......
Filter By Product Search for
Hydroxyproline
Hydroxyproline Full Name
Hydroxyproline
Hydroxyproline Introduction
Hydroxyproline is a non-essential amino acid generated primarily through the post-translational hydroxylation of proline residues by prolyl hydroxylases, making it one of the most distinctive biochemical signatures of collagen metabolism. Because nearly all hydroxyproline in mammals originates from collagen, its concentration has long been used as a reliable indicator of extracellular matrix (ECM) turnover, tissue remodeling, fibrosis, and wound repair. However, recent research has expanded its biological significance far beyond a structural collagen marker. Hydroxyproline is now recognized as a metabolically active molecule that participates in mitochondrial energy metabolism, redox homeostasis, and hypoxia adaptation through enzymes such as hydroxyproline oxidase (PRODH2/OH-POX) and collagen-modifying enzymes including P4HA1, P4HA2, and hypoxia-responsive prolyl hydroxylase domain proteins (PHDs/EGLNs). For researchers investigating fibrosis, cancer progression, or connective tissue disorders, understanding hydroxyproline metabolism provides valuable insight into how collagen remodeling is linked with intracellular signaling, oxidative stress, and disease progression rather than serving merely as a passive biomarker.
The biological functions of hydroxyproline are closely connected with several molecular targets that regulate collagen biosynthesis, oxygen sensing, and cellular metabolism. Among these, P4HA1 (Prolyl 4-Hydroxylase Subunit Alpha 1) catalyzes the hydroxylation of proline residues during collagen synthesis, ensuring proper collagen triple-helix stability and extracellular matrix organization. Increasing evidence shows that P4HA1 is strongly induced by hypoxia through HIF-1α, while oncogenic pathways involving STAT1, E2F transcription factors, and HIF2α further enhance its expression in aggressive tumors. Elevated P4HA1 promotes epithelial-mesenchymal transition (EMT), matrix remodeling, angiogenesis, invasion, metastasis, and resistance to chemotherapy, making it an attractive therapeutic target in multiple solid cancers. Equally important is PRODH2/OH-POX, the mitochondrial enzyme responsible for hydroxyproline degradation. Recent studies demonstrate that PRODH2 is transcriptionally activated by p53, linking hydroxyproline catabolism with reactive oxygen species (ROS) generation and p53-dependent apoptosis. Silencing PRODH2 significantly reduces ROS production and weakens apoptotic signaling, highlighting its role as a metabolic checkpoint that determines whether hydroxyproline supports cell survival or triggers programmed cell death. These interconnected pathways illustrate how hydroxyproline metabolism bridges extracellular matrix remodeling with mitochondrial function, oxidative stress, and tumor suppressor signaling.
Abnormal regulation of hydroxyproline-associated pathways has been implicated in a broad spectrum of human diseases, particularly fibrosis, cancer, chronic inflammation, and hypoxia-related disorders. Persistent activation of collagen hydroxylation enzymes leads to excessive extracellular matrix deposition, contributing to liver fibrosis, pulmonary fibrosis, renal fibrosis, cardiac fibrosis, and other progressive fibrotic diseases. In oncology, overexpression of P4HA1 has consistently been associated with poor prognosis in pancreatic, colorectal, breast, prostate, lung, ovarian, glioma, and esophageal cancers, where it enhances tumor invasion, metastatic potential, angiogenesis, and therapeutic resistance. Meanwhile, the HIF-PHD oxygen-sensing pathway has become an important therapeutic target because inhibition of PHD enzymes stabilizes HIF-α and improves erythropoiesis in chronic kidney disease-associated anemia. Nevertheless, prolonged activation of HIF signaling may also promote inflammation, immune remodeling, tumor vascularization, and cancer progression, emphasizing the double-edged nature of this pathway. Emerging evidence further suggests that hydroxyproline metabolism influences the tumor microenvironment by integrating collagen degradation, mitochondrial bioenergetics, ROS signaling, and hypoxic adaptation. As a result, molecular targets including P4HA1, PRODH2/OH-POX, and PHD family enzymes (EGLN1/PHD2, EGLN2/PHD1, EGLN3/PHD3) are increasingly regarded as promising biomarkers and therapeutic targets for precision medicine strategies aimed at treating fibrosis, solid tumors, inflammatory diseases, and disorders of extracellular matrix remodeling.
Alternate Names for Hydroxyproline
4-L-Hydroxyproline; delta-Hydroxyproline; Hypro; L-Proline,4-hydroxy-,trans; Ls-Hydroxyproline; trans-Hydroxyproline; H-HYP-OH; H-HYP-OH (TRANS); H-L-HYDROXYPROLINE; H-L-HYP-OH
Loading ......
